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Association of Triadin to the Junctional Sarcoplasmic Reticulum of
Skeletal Muscle Cells
Daniela Rossi, Cristina Bencini, Francesca Benini, Stefania Lorenzini,
Marina Maritati, Vincenzo Sorrentino.
University, Siena, Italy.
The junctional sarcoplasmic reticulum (jSR) of skeletal muscle cells contains
several proteins that participate to the mechanisms of Ca2þ release in the pro-
cess of excitation-contraction coupling. Among these proteins, ryanodine re-
ceptor, triadin, junctin and calsequestrin have been found to associate into a sta-
ble complex. We recently reported that assembly of jSR domains is
accompanied by a strong decrease in the mobility fraction of jSR proteins (Cu-
simano et al., PNAS 2009). In particular, we found that the mobility of triadin
appeared to be mediated by its intraluminal region (aa 232-729). In order to
identify the minimal regions required for association of triadin to the jSR, de-
letion mutants of the luminal domain (triadin D232-440 and triadin D441-729)
were generated and expressed in primary muscle myotubes. Analysis of the mo-
bility fraction of these mutants showed that they do not differ from wild type
triadin, indicating that either one of the two regions is sufficient to provide
a strong association of the protein to the jSR. Interestingly, we found that the
luminal region of triadin contains several defined domains, including a coiled
coil region and short amino acids repeats, that are present in the region between
aa 232-440 and aa 441-729, where they may mediate protein-protein interac-
tions. Results on the role of these amino acid repeats in mediating triadin asso-
ciation with the jSR will be reported.
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Time-Resolved FRET Detection of Structural Distributions Involving
FKBP12.6 and Calmodulin BoundWithin Macromolecular RyR Channels
Razvan L. Cornea, Florentin R. Nitu, David D. Thomas, Bradley R. Fruen.
UNIVERSITY OF MINNESOTA, Minneapolis, MN, USA.
We used multi-exponential analysis of time-resolved (TR) fluorescence decays
to investigate the array of distances underlying fluorescence resonance energy
transfer (FRET) between donors and acceptors bound within functional RyR
channels in sarcoplasmic reticulum membranes. Previously, we have used
steady-state (SS) FRET to demonstrate that CaM is oriented with the N-lobe
proximal to the FKBP12.6 subunit on each lateral face of the RyR tetrameric
complex (Cornea et al. 2009). Here, we used cysteine mutagenesis and sulfhy-
dryl-specific fluorescent labeling to attach Alexa Fluor (AF) donor probes to
single-cysteines at FKBP12.6 sites 49 or 85 (denoted D49 and D85), and accep-
tor probes to calmodulin (CaM) N-lobe sites 26 or 34 (denoted A26 and A34).
The fluorescence of RyR-bound donor-labeled FKBP12.6 was decreased in the
presence of saturating acceptor-labeled CaM, indicating FRET. Fo¨rster analysis
of TR- and SS-FRET data of donor/acceptor pairs AF350/AF488 and AF488/
AF568 (with different ranges of sensitivity) yielded similarly-ranked energy
transfer efficiencies: D85/A26 R D49/A26 > D49/D34 > D85/34. Distances
calculated from these FRET efficiencies are remarkably similar for the two dif-
ferent donor/acceptor probe pairs. However, this kind of analysis can extract
only averaged distances from an RyR sample in which distinct biophysical
states are known to co-exist. Further multi-exponential analysis of the donor-
only (AF350-FKBP12.6) and donorþacceptor (AF350-FKBP12.6/AF488-
CaM) TR-FRET data sets resolved at least two simultaneous distance popula-
tions for each pair of labeled sites. These distances and their distribution re-
sponded to changes in [Ca2þ]. We conclude that TR-FRET provides a powerful
approach for resolving dynamic transitions between structural states within
functional, multimeric RyR channels. Further studies will aim to determine
whether these findings reflect transitions between different conformations of
CaM itself, or of the underlying RyR channel.
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FKBP12.6 Inhibits Resting Ryanodine Receptor Activity but PKA-Depen-
dent Phosphorylation Does Not Alter FKBP12.6-RyR2 Binding in Rat Per-
meabilized Myocytes
Tao Guo1, Razvan Cornea2, Sabine Huke3, Emmanuel Camors4, Yi Yang4,
Eckard Picht4, Bradley Fruen4, Donald Bers4.
1Rush University Medical Center, Chicago, IL, USA, 2University of
Minnesota, Minneapolis, MN, USA, 3Vanderbilt University School of
Medicine, Nashville, TN, USA, 4University of California, Davis, CA, USA.
FK506-binding proteins FKBP12.6 and FKBP12 are associated with the car-
diac ryanodine receptor (RyR2), and PKA dependent hyperphosphorylation
of RyR2 has been proposed to interrupt the FKBP12.6-RyR2 interaction and
activate RyR2 opening. However, the physiological function of FKBP12.6/
12.0 in cardiac myocytes and the role of PKA-dependent RyR2 phosphoryla-
tion are controversial. We used permeabilized rat ventricular myocytes, and flu-
orescently-labeled FKBP12.6/12.0 to directly measure in situ binding ofFKBP12.6/12.0 to RyR2, with simultaneous Ca sparks measurements as an
RyR2 functional index. We found that both FKBP12.6 and FKBP12 concen-
trate at the Z-line, consistent with RyR2 binding. However, only FKBP12.6 in-
hibits resting RyR2 activity. Assessment of fluorescent FKBP binding at the Z-
line of permeabilized myocytes revealed a high affinity of FKBP12.6-RyR2
(Kd ¼ 0.97 5 0.1 nM) and much lower affinity of FKBP12-RyR2 (Kd ¼
2065 70 nM). Fluorescence recovery after photobleach of FKBP in myocytes
confirmed these different affinities and showed that the main difference was in
koff. Activation of RyR2 phosphorylation by PKA had no significant affect on
either binding kinetics or affinity of FKBP12.6/12-RyR2. Using quantitative
immunoblots, we determined the concentration of endogenous FKBP12 in in-
tact myocytes was ~1 mM, while FKBP12.6 is at most ~150 nM. Taken to-
gether, our data suggest that FKBP12.6 binds to and stabilizes the resting
RyR2 but cAMP-dependent RyR2 phosphorylation does not dissociate
FKBP12.6 (or FKBP12) from RyR2 in the myocyte environment. More impor-
tant, this study highlights the importance of in situ binding properties measure-
ment and clarifies some aspects of controversy.
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FKBP12 and FKBP12.6 Exert Opposing Actions on the Single-Channel
Behaviour of Both RyR1 and RyR2
Elisa Venturi1, Elena Galfre`1, Mano Sitsapesan1, Samantha Pitt1, Yan Dai1,
Stephen O’Neill2, Rebecca Sitsapesan1.
1University of Bristol, Bristol, United Kingdom, 2University of Manchester,
Manchester, United Kingdom.
It is widely believed, that in striated muscle, FKBP12.6 selectively binds to
RyR2 but that FKBP12 is the binding partner for RyR1. Few studies have ad-
dressed whether FKBP12 can modulate RyR2 function or whether FKBP12.6
can affect RyR1. Our recent single-channel studies show that FKBP12 activates
RyR2 with nanomolar affinity but because binding is rapidly reversible, this in-
teraction is unlikely to be detected by Western blot analysis. We have therefore
compared how FKBP12 and FKBP12.6 affect the single-channel properties of
RyR1 and RyR2 reconstituted into bilayers. Using Ca2þ as the permeant ion,
cytosolic addition of 500 nM FKBP12 significantly decreased the open proba-
bility (Po) of RyR1 from 0.0215 0.005 (SEM; n ¼ 4) in controls to 0.0015
0.001 (SEM; n ¼ 4; P<0.05). This effect was irreversible after perfusing away
the FKBP12. In contrast, 200 nM and 1 mMFKBP12.6 increased RyR1 Po. This
effect was also irreversible after washout of FKBP12.6 but could be antagon-
ised by addition of FKBP12. In comparison, FKBP12 is a reversible activator
of RyR2 whereas FKBP12.6 has little intrinsic action itself but can antagonise
FKBP12-induced activation. The presence or absence of FKBP12/12.6 did not
lead to the appearance of sub-conductance gating states in RyR2 but, after FK-
506 treatment or addition of FKBP12.6 to RyR1, sub-conductance states were
frequently observed. Since FKBP12 activates RyR2 but is antagonised by
FKBP12.6, and FKBP12.6 activates RyR1 but is antagonised by FKBP12,
the ratio of FKBP12/FKBP12.6 levels in the cytoplasm will be critical in deter-
mining RyR activity in situ. Changes in the cytoplasmic FKBP12/FKBP12.6
ratio may be important in heart failure, where it has been suggested that less
FKBP12.6 binds to RyR2.
Supported by the British Heart Foundation
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Use of Rapamycin Reveals Evidence of the Physiological Roles of FKBP12
and FKBP12.6 In Cardiac Excitation-Contraction Coupling
Elena Galfre`1, Elisa Venturi1, Samatha J. Pitt1, Mano Sitsapesan1,
Rebecca Sitsapesan1, Stephen O’Neill2.
1University of Bristol, Bristol, United Kingdom, 2University of Manchester,
Manchester, United Kingdom.
A huge body of evidence suggests that FKBP12.6, which binds tightly to RyR2,
is an important physiological regulator of cardiac excitation-contraction (EC)
coupling yet its mechanism of action remains elusive. Our recent single-chan-
nel studies now reveal that RyR2 activity may be controlled by the opposing
actions of FKBP12.6 and FKBP12. To investigate how these proteins regulate
RyR2 function in cardiac cells we have used rapamycin to dissociate FKBP12
and FKBP12.6 from RyR2 in isolated rat permeabilised ventricular myocytes.
In control myocytes perfused with Fluo-5F, spontaneous waves of Ca2þ-in-
duced Ca2þ-release were induced by 234 nM Ca2þ in the mock cytoplasmic so-
lution. Treatment for 4-6 min with 20 mM rapamycin, reduced the frequency of
the Ca2þ-waves from 0.5750.07 Hz to 0.1850.05 Hz (SEM; n¼5; P<0.002)
and led to the appearance of ‘mini-waves’ that did not propagate throughout the
cell. Rapamycin treatment also increased baseline Fluo-5F fluorescence inten-
sities by 204547% (SEM; n¼8; P<0.05), an effect that was completely re-
versed by perfusion with a physiological level of FKBP12 (3 mM; n¼4;
P<0.001) but not with 200 nM FKBP12.6 (n=4). In rapamycin-treated cells,
FKBP12 (from 0.1550.06 Hz to 0.2750.07 Hz (SEM; n¼6; P<0.025) was
300a Monday, February 22, 2010able to increase wave frequency. On the other hand, FKBP12.6 was not (from
0.1250.04 Hz to 0.1650.04 Hz (SEM; n¼4; P>0.35). Our results indicate
that FKBP12 may have an important role as an activator of RyR2 in cardiac
cells. Further work is required to determine the individual and combined roles
of FKBP12 and FKBP12.6 in cardiac EC-coupling.
Supported by the British Heart Foundation.
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FKBP12 is a High Affinity, Reversible Activator of RyR2, and FKBP12.6
Antagonises Its Actions
Rebecca Sitsapesan1, Samantha J. Pitt1, Elisa Venturi1, Elena Galfre1,
Stephen O’Neill2, Mano Sitsapesan1.
1University of Bristol, Bristol, United Kingdom, 2University of Manchester,
Manchester, United Kingdom.
FKBP12.6 binds tightly to RyR2 and evidence suggests that it plays a vital
physiological role in regulating channel activity. Moreover, changes in
FKBP12.6/RyR2 interactions have been implicated in heart failure. Contro-
versy exists, however, as to how FKBP12.6 affects the single-channel behav-
iour of RyR2. Furthermore, although higher levels of FKBP12 than
FKBP12.6 are present in cardiac cells, the effects of FKBP12 on RyR2 are vir-
tually unresearched. We have therefore compared the effects of FKBP12 and
FKBP12.6 on the single-channel function of sheep RyR2 incorporated into
bilayers under voltage-clamp conditions. We find that FKBP12 increases
RyR2 open probability (Po) in a dose-dependant, reversible manner with an
EC50 of 51 nM. In the presence of 10 mM cytosolic Ca
2þ, physiological levels
of FKBP12 (3 mM) increased Po from 0.18750.051 in controls to
0.65750.111 (SEM; n¼14; P<0.001). In contrast, under identical experimen-
tal conditions, FKBP12.6 did not significantly increase or decrease RyR2 Po,
however, it was able to antagonise the actions of FKBP12, shifting the EC50
value for FKBP12 to 4 mM. Our experiments demonstrate that FKBP12 has
high affinity for RyR2 and that at physiological concentrations (1-3 mM) is
an effective activator of the channel thereby suggesting that FKBP12 may
have a more important role in cardiac excitation-contraction coupling than pre-
viously thought. We hypothesise that FKBP12.6 is a very low efficacy (but high
affinity) partial agonist of RyR2 and that the balance between the effects of
FKBP12 and FKBP12.6 is crucial for normal EC-coupling in cardiac cells.
Supported by the British Heart Foundation
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Imperatoxin Induces a Biphasic Response in Ca2þ Sparks
Erin M. Capes, Hector H. Valdivia.
University of Wisconsin-Madison, Madison, WI, USA.
Imperatoxin induces a biphasic response in Ca2þ sparks
Imperatoxin A (IpTxa), isolated from the venom of the African scorpion Pandi-
nus imperator, has been shown to specifically activate ryanodine receptors
(RyR) and to be capable of translocating across cell membranes. IpTxa enhances
[3H]ryanodine binding to sarcoplasmic reticulum (SR) and stabilizes subcon-
ducting states in single channels. We previously demonstrated that IpTxa alters
the amplitude of calcium transients in intact field-stimulated cells, causing
a rapid increase in transient amplitude. This is followed by a gradual decrement
in amplitude to a new steady state at lower amplitude than in control. The current
study seeks to clarify how IpTxa acts on RyRs to perturb Ca2þ handling in car-
diomyocytes. We employed visualization of IpTxa-modified Ca2þ sparks in sa-
ponin-permeabilized cells to facilitate direct titration of RyRs with known con-
centrations of IpTxa, ranging from500pM to 50nM. In addition,wemodified our
sparks protocol to enable a comparison of the caffeine-releasable SR Ca2þ load
before and after treatment with the toxin. Our results demonstrate that IpTxa in-
duces a biphasic RyR response, typified by a transient increase in spark fre-
quency, amplitude, FWHM, and FDHM, which is rapidly followed by a sharp
decrease in the same parameters. Comparison of pre- and post-toxin caffeine-re-
leasableSRCa2þ consistently reveals that SRcontent hasbeen reducedas a result
of IpTxa perfusion to approximately 75%of control. These results are consistent
with the biphasic response observed in Ca2þ transient experiments. We believe
that IpTxa sensitizesRyR to luminal Ca2þ, leading to increasedCa2þ release and
subsequent depletion of Ca2þ from the SR. Our findings have exciting implica-
tions for translational research into cardiac diseases such as catecholaminergic
polymorphic ventricular tachycardia, in which acute RyR hyperactivity is hy-
pothesized to trigger arrhythmias leading to sudden cardiac death.
1564-Pos
Role of Hydrophobic Interactions in the Block of the Ryanodine Receptor
by Shaker B Inactivation Peptides
Cedric Viero1, Sammy Mason1, Mark Bannister2, Matthew Davies1,
Alan J. Williams1.
1Wales Heart Research Institute, Cardiff, United Kingdom, 2Imperial
College, London, United Kingdom.Shaker B Kþ channel NH2-inactivation peptides (ShBP) block both sheep and
mouse cardiac ryanodine receptor Ca2þ release channels (RyR2). We provide
new evidence for the presence of hydrophobic residues in the conduction path-
way of RyR2 and their role in the block by wild-type (WT) and mutant ShBP.
RyR2 proteins were expressed in HEK cells, purified and their single channel
activity recorded in lipid bilayers. Four peptides were synthesised and tested: i)
WT ShBP MAAVAGLYGLGEDRQHRKKQ, ii) a ‘‘less hydrophobic’’ pep-
tide (LHBP) MAQVQGLYGLGEDRQHRKKQ, and 2 ‘‘more hydrophobic’’
peptides (MHBP), iii) MHBPI MAVVAGLYGLGEDRQHRKKQ and iv)
MHBPII MAAVVGLYGLGEDRQHRKKQ. All peptides blocked the ryano-
dine-modified RyR2 channel from the cytosolic face in a concentration- and
voltage-dependent manner. At a holding potential of þ50 mV in symmetrical
210 mM KCl, we found an affinity constant KD of 39.545 3.90 mM for WT
ShBP, 65.90 5 12.99 mM for LHBP, 27.79 5 4.29 mM for MHBPI and
44.56 5 9.38 for MHBPII. The association rates Kon of the peptides varied
with concentration (2.92 5 0.08 s1.mM1 for WT ShBP, 3.85 5 0.32
s1.mM1 for LHBP, 2.96 5 0.22 s1.mM1 for MHBPI and 2.31 5 0.25
s1.mM1 for MHBPII). Dissociation rates Koff were independent of concentra-
tion (115.305 7.90 s1 for WT ShBP, 253.525 24.49 s1 for LHBP, 82.145
5.48 s1 for MHBPI and 102.97 5 8.30 s1 for MHBPII). Furthermore the
block induced by the peptides could be reduced by an increase of the salt con-
centration at the luminal side of the channel. These findings indicate that hydro-
phobic interactions between RyR2 and inactivation peptides are necessary for
the block, and that the binding sites of the peptides are within the pore. This
research was supported by the BHF.
1565-Pos
Crystallographic Insights into the Cardiac Ryanodine Receptor N-termi-
nal Domain and its Disease Mutants
Paolo A. Lobo, Filip Van Petegem.
University of British Columbia, Vancouver, BC, Canada.
Ryanodine receptors (RyRs) are large channels governing the release of Ca2þ
from the sarcoplasmic or endoplasmic reticulum. They are required for the con-
traction of both skeletal (RyR1) and cardiac muscles (RyR2). Mutations in RyR
genes have been associated with severe genetic disorders, but high-resolution
data describing the disease variants in detail has been lacking. We have solved
the crystal structures of the N-terminal domains of both RyR2 (2.55A˚) and
RyR1 (3.0A˚), along with structures of various RyR2 disease mutants. The N-
terminal domain in both RyR1 and RyR2 consists of a core beta trefoil domain
flanked by an alpha helix. Two cysteine pairs display a highly increased flexi-
bility, making them ideal candidates to receive redox modifications. Crystal
structures of several RyR2 disease mutants (1.7A˚ - 2.2A˚) show that most of
the mutations cause distinct local changes to the surface of the protein, high-
lighting at least two putative binding interfaces required for normal RyR func-
tion. One RyR2 disease mutant causes significant changes in the thermal stabil-
ity of the N-terminal domain, accompanied by large conformational changes in
the structure.
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StructuralMapping of the Ryanodine Receptor Type 1 Using A Fret-Based
Method
James D. Fessenden.
Boston Biomedical Research Institute, Watertown, MA, USA.
The type 1 ryanodine receptor (RyR1) mediates excitation contraction coupling
in skeletal muscle by releasing stored intracellular calcium in response to cel-
lular depolarization. This 2.2 MDa homotetrameric protein is associated with
numerous regulatory proteins that modulate its activity in vivo. Understanding
the structure and conformational dynamics of this immense macromolecular
complex is an enormous challenge in skeletal muscle biology. In this report,
structural determinations of RyR1 were performed using Fo¨rster resonance en-
ergy transfer (FRET) measurements. In this system, the FRET donor was green
fluorescent protein (GFP) fused to RyR1, which could then transfer energy to
Cy3NTA, a site-specific FRET acceptor targeted to poly-histidine segments in-
serted into RyR1. Energy transfer was monitored as a decrease in GFP fluores-
cence occurring when Cy3NTAwas bound to a His tag in close proximity to the
GFP donor fused either to position 1 or position 618 of RyR1. Cy3NTA was
targeted to each of three ‘‘divergent regions’’ (DR) poorly conserved among
the three RyR isoforms (DR1; position 4430, DR2; position 1323, DR3; posi-
tion 1861). While minimal FRET was detected between N-terminally fused
GFP and Cy3NTA targeted to these divergent regions, significant energy trans-
fer was detected from GFP at position 618 to Cy3NTA targeted to DR2 or DR3.
These experiments indicate that these donor and acceptor sites are in close
proximity to each other and also demonstrate the utility of this FRET-based
technique for further structural mapping of RyR1. (Supported by NIH grant
R21ARO56406).
